Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 14/20 | 1.00 |
| ▸ | MMP9 | P14780 | 14/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.64 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.64 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.64 |
| ▸ | EGFR | P00533 | 3/20 | 0.53 |
| ▸ | ERBB2 | P04626 | 3/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27954382 | 0.87 | MMP2 (0.77) | MMP2MMP9L3MBTL1 | |
| SCHEMBL27991839 | 0.86 | MMP2 (0.75) | MMP2MMP9L3MBTL1PTGS1PTGS2 | |
| SCHEMBL27992049 | 0.80 | MMP2 (1.00) | MMP2MMP9L3MBTL1PTGS1PTGS2 | |
| SCHEMBL27992058 | 0.79 | MMP2 (0.78) | MMP2MMP9L3MBTL1PTGS1PTGS2 | |
| SCHEMBL27944763 | 0.72 | L3MBTL1 (0.69) | MMP2MMP9L3MBTL1EGFRERBB2 | |
| SCHEMBL28810693 | 0.71 | L3MBTL1 (0.79) | MMP2MMP9L3MBTL1PTGS2 | |
| SCHEMBL5856319 | 0.71 | PTGS1 (0.73) | MMP2MMP9L3MBTL1PTGS1PTGS2 | |
| SCHEMBL9356235 | 0.70 | EGFR (1.00) | MMP2MMP9EGFRERBB2 | |
| SCHEMBL5857978 | 0.69 | CA2 (0.56) | MMP2MMP9L3MBTL1PTGS1PTGS2 | |
| SCHEMBL27954385 | 0.68 | CA2 (0.76) | MMP2MMP9L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104230904-A | Synthesis of dihydropyrazol sulfonamide derivatives containing naphthalene ring skeletons and application of dihydropyrazol sulfonamide derivatives in anti-cancer drugs | NANJING UNIVERSITY OF TECHNOLOGY | 2014-12-24 | — | — | CN | disclosed |